Lymphocytes were infected with the QIMR-WIL strain of Epstein-Barr virus, and the induction of Epstein-Barr virus-associated nuclear antigens was determined by using the protein immunoblot. There was a temporal increase in six antigens, with Epstein-Barr nuclear antigen 2 being detected 1 day after infection. The appearance of these antigens was shown to be independent of cellular DNA synthesis.
Epstein-Barr virus (EBV) transforms human B lymphocytes into continuously proliferating lymphoblastoid cell lines (7, 16) . These transformed cell lines express the EBV nuclear antigen (EBNA) which has traditionally been detected by the anticomplement immunofluorescence test (17) . More recent evidence has demonstrated the existence of multiple EBV-specific antigens in EBV-transformed cells. The most prominent antigen (EBNA 1) is a polypeptide partially encoded by the BamHI K fragment, and the second (EBNA 2) is a polypeptide encoded by the BamHI WYH region (3, 4, 6, 8, (19) (20) (21) .
Using protein immunoblots, we previously reported the existence of six EBV-induced nuclear antigens in cells transformed with QIMR-WIL virus (19) . The most prominent of these antigens had a molecular weight of 92,000. We have recently shown that this 92,000-dalton (92K) polypeptide defined by protein immunoblot and EBNA 2 are identical. This conclusion is based, first, on the fact that the 92K protein is not detected in cell lines with a deletion or alteration in the BamHI WYH region (T. B. Sculley, G. W. Bornkamm, and A. B. Rickinson, manuscript in preparation). Second, sera that yield a positive 92K reaction also detect EBNA 2 (K. Hennessy, manuscript in preparation).
EBNA 1 has been detected in B lymphocytes 1 to 2 days after infection by the anticomplement immunofluorescence test (1, 15), while cellular DNA synthesis begins about 40 h postinfection (1, 5, 11) and mitosis and cell division begin about 8 h later (24) . The present report has examined the induction of EBNA 1, EBNA 2, and other EBV-specific nuclear proteins and their relationship to cellular DNA synthesis.
The T-cell-depleted population (referred to as B lymphocytes) was separated from cord blood (12) , infected (at 0.25 transforming dose per cell) with the QIMR-WIL strain of EBV (15) , and cultured at 106 cells per ml in either Linbro (2-ml cultures) or flat-bottomed microtiter (0.2-ml cultures) plates. Cells were harvested daily for 4 days by centrifugation, and the pellets were solubilized in sodium dodecyl sulfate and applied to a 10% polyacrylamide-sodium dodecyl sulfate gel (9) . After electrophoresis, the separated proteins were transferred to nitrocellulose paper (18) , and antigens were detected by incubation with serum (known to contain antibody to EBNA 1 and EBNA 2) and radioiodinated protein A (70 to 100 ,XCi/,ug).
To determine whether cellular DNA synthesis was required for the induction of EBNA 1 and EBNA 2, two fully reversible procedures were adopted which block cells in Gl. In the first approach, cellular DNA synthesis was inhibited * Corresponding author.
by the addition of the calcium-chelating agent ethylenebis(oxyethylenenitrilo)tetraacetic acid (EGTA) at a concentration of 0.92 mM (equivalent to 8 ,uM available calcium in the growth medium) (2, 12, 14). In the second approach, unlabeled thymidine was added to a final concentration of 10 mM. This procedure is known to block cells in Gl (10) . The establishment of the DNA block at the G1-S boundary was confirmed by propidium iodide staining and analysis on the fluorescence-activated cell sorter (21) . Both procedures resulted in >95% of cells with a presynthetic DNA value characteristic of Gi, while <60% of untreated cells were in Gi (data not shown). In the case of cells treated with EGTA, the block was further confirmed by monitoring the level of
[14C]thymidine incorporation during the first 4 days of culture (Fig. 1) .
The results of a single experiment (representive of the four performed) are presented in Fig. 2 , in which B lymphocytes were harvested 0, 1, 2, 3, and 4 days after infection with EBV. Induction of EBV-specific antigens was determined by using the protein immunoblot. There was a temporal increase in the intensity of the six antigens (110/115K, 92K, 73K, 55K, and 45K) to day 4, when a reaction could be reproducibly demonstrated (Fig. 2) . As previously reported, these antigens are all located in the nucleus (19) . An analysis of the bands on the X-ray film by densitometry (LKB 2202 Ultroscan Laser Densitometer with Gelscan software package) (Fig. 3) 40K and 42K but, because of the faintness of the reaction, the EBV specificity of these bands is unproven.
The sequence of synthesis of the six EBV-specific proteins is an important consideration. The densitometer tracing (Fig.  3) reveals that the intensity of staining of four of these antigens (EBNA 2, EBNA 1 complex, 55K, and 45K) relative to each other remained constant throughout the time period studied. It thus seems likely that these four antigens were synthesized simultaneously (the precise time of synthesis of these antigens is limited by the sensitivity of the immunoblot assay). It seems unlikely that the 45K and 55K bands represent degradation products of EBNA 2 or the EBNA 1 complex since some human sera have been found to react with all four antigens while other sera react only with EBNA 2 and the EBNA 1 complex (unpublished result). It is not possible at this stage to determine whether the reproducible delay in the appearance of the 100/115K antigens indicates a delay in the synthesis of these antigens or is a reflection of the sensitivity of the assay used to detect them.
B lymphocytes infected with EBV and cultured for 4 days in either EGTA (Fig. 2) or thymidine (not shown) expressed both EBNA 1 (as a single band) and EBNA 2 (as a triplet), 110/115K, 55K, and 45K. Cells released from the EGTA block by addition of 0.5 M CaCl2 or the thymidine block by washing cells in growth medium expressed the same five antigens and resulted in a rapid increase in the incorporation of [14C]thymidine (in the case of the EGTA block) (Fig. 1 ).
These results demonstrate that both EBNA 1 and EBNA 2, together with the other EBV-specific proteins, are induced within 1 to 2 days after infection with QIMR-WIL. The nature of the three EBNA 2 bands is not known, though it is possible that the multiple bands are a modified form of a single antigen (i.e., phosphorylated, glycosylated, etc.). It will now be important to determine whether modified forms of EBNA 2 exist in lines transformed by other strains of EBV.
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